These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 16675195)
1. Design and development of liposomes incorporating a bioactive labdane-type diterpene. In vitro growth inhibiting and cytotoxic activity against human cancer cell lines. Matsingou C; Dimas K; Demetzos C Biomed Pharmacother; 2006 May; 60(4):191-9. PubMed ID: 16675195 [TBL] [Abstract][Full Text] [Related]
2. Labdane-type diterpenes: thermal effects on phospholipid bilayers, incorporation into liposomes and biological activity. Matsingou C; Hatziantoniou S; Georgopoulos A; Dimas K; Terzis A; Demetzos C Chem Phys Lipids; 2005 Dec; 138(1-2):1-11. PubMed ID: 16182267 [TBL] [Abstract][Full Text] [Related]
3. Calorimetric study on the induction of interdigitated phase in hydrated DPPC bilayers by bioactive labdanes and correlation to their liposome stability: The role of chemical structure. Matsingou C; Demetzos C Chem Phys Lipids; 2007 Jan; 145(1):45-62. PubMed ID: 17116297 [TBL] [Abstract][Full Text] [Related]
4. Cytotoxic and antitumor activity of liposome-incorporated sclareol against cancer cell lines and human colon cancer xenografts. Hatziantoniou S; Dimas K; Georgopoulos A; Sotiriadou N; Demetzos C Pharmacol Res; 2006 Jan; 53(1):80-7. PubMed ID: 16253514 [TBL] [Abstract][Full Text] [Related]
5. A liposomal formulation of doxorubicin, composed of hexadecylphosphocholine (HePC): physicochemical characterization and cytotoxic activity against human cancer cell lines. Papagiannaros A; Hatziantoniou S; Dimas K; Papaioannou GT; Demetzos C Biomed Pharmacother; 2006 Jan; 60(1):36-42. PubMed ID: 16271845 [TBL] [Abstract][Full Text] [Related]
6. Doxorubicin-PAMAM dendrimer complex attached to liposomes: cytotoxic studies against human cancer cell lines. Papagiannaros A; Dimas K; Papaioannou GT; Demetzos C Int J Pharm; 2005 Sep; 302(1-2):29-38. PubMed ID: 16099117 [TBL] [Abstract][Full Text] [Related]
7. A comparative study of the effects of cholesterol and sclareol, a bioactive labdane type diterpene, on phospholipid bilayers. Kyrikou I; Georgopoulos A; Hatziantoniou S; Mavromoustakos T; Demetzos C Chem Phys Lipids; 2005 Feb; 133(2):125-34. PubMed ID: 15642582 [TBL] [Abstract][Full Text] [Related]
8. Encapsulation of naturally occurring flavonoids into liposomes: physicochemical properties and biological activity against human cancer cell lines. Goniotaki M; Hatziantoniou S; Dimas K; Wagner M; Demetzos C J Pharm Pharmacol; 2004 Oct; 56(10):1217-24. PubMed ID: 15482635 [TBL] [Abstract][Full Text] [Related]
9. Antitumor activity of doxorubicin encapsulated in hexadecylphosphocholine (HePC) liposomes against human xenografts on Scid mice. Papagiannaros A; Hatziantoniou S; Lelong-Rebel IH; Papaioannou GT; Dimas K; Demetzos C In Vivo; 2006; 20(1):129-35. PubMed ID: 16433041 [TBL] [Abstract][Full Text] [Related]
10. Solubilization of negatively charged DPPC/DPPG liposomes by bile salts. Hildebrand A; Beyer K; Neubert R; Garidel P; Blume A J Colloid Interface Sci; 2004 Nov; 279(2):559-71. PubMed ID: 15464825 [TBL] [Abstract][Full Text] [Related]
11. Cytotoxic activity of labdane type diterpenes against human leukemic cell lines in vitro. Dimas K; Demetzos C; Marsellos M; Sotiriadou R; Malamas M; Kokkinopoulos D Planta Med; 1998 Apr; 64(3):208-11. PubMed ID: 9581515 [TBL] [Abstract][Full Text] [Related]
12. Accumulation of vinblastine into transfersomes and liposomes in response to a transmembrane ammonium sulfate gradient and their cytotoxic/cytostatic activity in vitro. Maswadeh H; Demetzos C; Dimas K; Hatziantoniou S; Georgopoulos A; Rallis M; Dallas P; Papaioannou G Anticancer Res; 2001; 21(4A):2577-83. PubMed ID: 11724324 [TBL] [Abstract][Full Text] [Related]
13. An in vitro study of liposomal curcumin: stability, toxicity and biological activity in human lymphocytes and Epstein-Barr virus-transformed human B-cells. Chen C; Johnston TD; Jeon H; Gedaly R; McHugh PP; Burke TG; Ranjan D Int J Pharm; 2009 Jan; 366(1-2):133-9. PubMed ID: 18840516 [TBL] [Abstract][Full Text] [Related]
14. Reduced toxicity and superior therapeutic activity of a mitomycin C lipid-based prodrug incorporated in pegylated liposomes. Gabizon AA; Tzemach D; Horowitz AT; Shmeeda H; Yeh J; Zalipsky S Clin Cancer Res; 2006 Mar; 12(6):1913-20. PubMed ID: 16551877 [TBL] [Abstract][Full Text] [Related]
15. Liposomes modify the subcellular distribution of sclareol uptake by HCT-116 cancer cell lines. Paradissis A; Hatziantoniou S; Georgopoulos A; Psarra AM; Dimas K; Demetzos C Biomed Pharmacother; 2007; 61(2-3):120-4. PubMed ID: 17270382 [TBL] [Abstract][Full Text] [Related]
16. Effectiveness of liposomal paclitaxel against MCF-7 breast cancer cells. Heney M; Alipour M; Vergidis D; Omri A; Mugabe C; Th'ng J; Suntres Z Can J Physiol Pharmacol; 2010 Dec; 88(12):1172-80. PubMed ID: 21164564 [TBL] [Abstract][Full Text] [Related]
18. Antimicrobial effectiveness of liposomal polymyxin B against resistant Gram-negative bacterial strains. Alipour M; Halwani M; Omri A; Suntres ZE Int J Pharm; 2008 May; 355(1-2):293-8. PubMed ID: 18164881 [TBL] [Abstract][Full Text] [Related]
19. Cytotoxic and anti-inflammatory activity of labdane and cis-clerodane type diterpenes. Demetzos C; Dimas K; Hatziantoniou S; Anastasaki T; Angelopoulou D Planta Med; 2001 Oct; 67(7):614-8. PubMed ID: 11582537 [TBL] [Abstract][Full Text] [Related]
20. Development and in vitro evaluation of a liposomal vaginal delivery system for acyclovir. Pavelić Z; Skalko-Basnet N; Filipović-Grcić J; Martinac A; Jalsenjak I J Control Release; 2005 Aug; 106(1-2):34-43. PubMed ID: 15979189 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]